業績

Kazuro Kamada, Michihito Kono, Tatsuya Atsumi  

Subacute finger gangrene with severe Raynaud’s phenomenon      Intern Med, in press            IF 1

Kazuro Kamada, Yuichiro Fujieda, Mika Watanabe, Tatsuya Atsumi  Skin Eruption and Nerve Impairment: Eosinophil Activation Link           J Rheumatol, in press       IF 3.6

Kitsunai H, Shinozaki Y, Furusawa S, Kitao N, Ito M, Kurihara H, Oba-Yamamoto C, Takeuchi J, Nakamura A, Takiyama Y, Nomoto H.         

The Effect of Oral Semaglutide on Hepatic Fibrosis in Subjects with Type 2 Diabetes in Real-World Clinical Practice: Post-Hoc Analysis of the Sapporo-Oral SEMA Study      Pharmaceuticals, in press　

IF: 4.3

Yuka Suzuki MD, Aika Miya MD, PhD, Akinobu Nakamura MD, PhD, Takahisa Handa MD, PhD, Hiraku Kameda MD, PhD, Tatsuya Atsumi MD, PhD Perception of hyper-/hypoglycemia and its related factors in type 2

diabetes: A continuous glucose monitoring based prospective observational study Diabetology International, in press IF 1.3

Takahashi A, Nomoto H*, Yokoyama H, Yokozeki K, Furusawa S, Oe Y, Kameda R, Kawata S, Miyoshi A, Nagai S, Miya A, Kameda H, Nakamura A, Atsumi T.

Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: A multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study).

Diabetes Obes Metab, in press

IF 5.4

Moriya H, Fujieda Y, Inoue Y, Miyamoto K, Anada M, Tanaka D, Kudo A, Abe M, Nagai A, Hisada R, Kono M, Kato M, Amengual O, Matsuno Y, Yabe I, Atsumi T Muscle vasculitis in patients with polymyalgia rheumatica; three case series Modern Rheumatology Case Reports

IF: 0.97

Targeting Complement in Kidney Transplantation: Therapeutic Approaches Based on  Preclinical and Experimental Evidence Nakazawa D.

Transplantation Reviews, in press.

IF 3.6　

Effects of Canagliflozin on brain natriuretic peptide level in patients with type 2 diabetes on peritoneal dialysis in Japan:

protocol for a multicenter, prospective, randomized controlled trial (CARD-PD trial) Naoko M, Daigo N, Saori N, Kyu Y. C., Tomochika M, Nobuharu K, Rie Y, Junya Y, Mamiko S, Minoru M, Satoko I, Kento I, Yosuke I, Akiko K, Takashi K, Junpei Y, Takahiro N, Yoichi I, Tatsuya A.

BMJ open

IF: 2.4　

Hisada R, Kono M

Recent advances in immunometabolism in rheumatic diseases Current Opinion in Rheumatology. in press

Meroni PL, Borghi MO, Amengual O, Atsumi T, Bertolaccini L, Cohen H, Grossi C, Roubey R, Sciascia S, Tebo A, Willis R, Erkan D, Devreese KMJ. 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria Solid Phase-based Antiphospholipid Antibody (aPL) Domain - Collaborative Efforts of APS ACTION and ISTH-SSC to Harmonize ELISA and non-ELISA aPL Tests: Communication from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.

J Thromb Haemost. 2024 Oct 10:S1538-7836(24)00569-5. doi:

10.1016/j.jtha.2024.09.021. Epub ahead of print.